Mead Johnson - About the deal

Investors

About the deal

Reckitt Benckiser Group plc signed a merger agreement with Mead Johnson Nutrition Company under which Mead Johnson shareholders received $90 per share in cash. 

The acquisition takes RB into a global market leadership in consumer health. The addition of the Enfa family of brands, the world’s leading franchise in infant and children’s nutrition is a natural extension to RB’s consumer health portfolio of Powerbrands which are already trusted by millions of mothers, reinforcing the importance of health and hygiene for their families.

Mead Johnson’s geographic footprint significantly strengthens our position in developing markets, which account for approximately 40% of the combined group’s sales.

RB’s deep understanding of consumer needs and its expertise in scaling global brands deliver significant growth for the Mead Johnson portfolio.

The deal

A significant step forward in consumer health for RB in a structurally attractive category

$90 RB acquires Mead Johnson for $90 per share in cash

$16.6 billion valuing Mead Johnson's equity at $16.6bn

$17.9 billion total value of the transaction is $17.9bn including Mead Johnson's net debt

Press Releases

RB & Mead Johnson Information

Contact us

RB

Richard Joyce - SVP, Investor Relations, Communications & External Affairs

Patty O'Hayer - Director, External Relations and Government Affairs

+44 (0)1753 217 800

 

Brunswick


Gabrielle Silver
David Litterick

+44 (0) 207 404 5959

Robey Warshaw and BofA Merrill Lynch are acting as joint lead financial advisers to RB.
Deutsche Bank is acting as financial adviser and corporate broker to RB.
HSBC is acting as financial adviser to RB.

Davis Polk & Wardwell LLP and Linklaters LLP are retained as legal advisers to RB.